Al-Ghaf Dynamics

Al-Ghaf Dynamics Transforming Healthcare in the Middle East through Strategy, Innovation & Impact. UAE-based data driven firm providing custom solutions.

28/08/2026

🇰🇼 517 medicines and pharmaceutical products have received new or reduced prices in Kuwait.

The decision covers treatments across oncology, cholesterol management, epilepsy, allergy and pain, antibiotics, antifungals and smoking cessation.

The Ministry of Health says this brings the total number of products covered by pricing and price-reduction decisions during the past three years to 2,760.

But there is an important qualification:

⚠️ The complete product list, previous and revised prices, percentage reductions, implementation date and inventory-transition rules have not yet been published.

For patients, lower prices could improve affordability—particularly if the reductions reach private pharmacies.

For manufacturers and distributors, the implications could include revenue exposure, inventory management, launch sequencing and regional reference pricing.

🎥 In today’s , I ask the question that now matters most:

Will lower medicine prices translate into wider patient access?

وزارة الصحة - الكويت Kuna Ar Kuwait Times

Sources are included in the first comment.

Localization quotas are rising across GCC healthcare. What’s the biggest lever for closing the clinical talent gap? With...
28/08/2026

Localization quotas are rising across GCC healthcare. What’s the biggest lever for closing the clinical talent gap?
With Saudi hospitals now facing a 65% Saudization requirement from July 2026, and similar workforce-nationalization priorities across the Gulf, we want your view.
What do you believe is the most effective lever for closing the region’s clinical talent gap?
A. Local training and residency pipelines
B. Retention incentives for existing talent
C. Streamlined cross-border licensing (GCC-wide recognition)
D. Continued reliance on international recruitment for specialist roles
Vote and share your reasoning in the comments.

27/08/2026

🇴🇲 93.1%. That is the proportion of adults reported to have at least one NCD risk factor in Oman’s latest national survey.

The findings also reported:

⚖️ 64.7% overweight or obese
❤️ 28.8% hypertension
🩸 13.4% diabetes
🏃 27.9% below recommended physical-activity levels

The survey used a WHO-approved approach and a nationally representative sample.

However, the full technical report is still important before drawing detailed conclusions about specific age groups, populations or governorates.

Oman will look to integrated metabolic-risk management.

Screening, obesity, diabetes, hypertension, cardiovascular risk, employer health and measurable outcomes increasingly need to be treated as one connected population-health challenge.

🎥 More in today’s Majlis Minute.

Where should Oman intervene first?

وزارة الصحة- سلطنة عُمان

📖 Source:
https://omannews.gov.om/topics/en/79/show/127169

26/08/2026

After the consultation, who makes sure the next step actually happens?

In Episode 4 of Health Majlis, Dr Paul Setlak speaks with Ahmad Shraim, Founder and CEO of AloTabib, about the loss of continuity between consultation, prescriptions, diagnostics and recovery.

They explore:
-> What AI may coordinate - and what clinicians must decide
-> How an Arabic-first system should handle dialect, context and uncertainty
-> What meaningful patient control looks like
-> Which evidence matters beyond registrations and provider interest
-> Why Jordan comes first, and what should be proved before GCC expansion
-> How commercial incentives can remain aligned with appropriate care

AloTabib is an early-stage venture with a technically demonstrated MVP. Real-world operating proof remains ahead - and the episode asks exactly what that proof should include.

Watch the full episode through the link in bio.

What is the one healthcare decision AI should never make autonomously?

Regional organisations referenced: مجلس الصحة الخليجي وزارة الصحة السعودية وزارة الصحة ووقاية المجتمع وزارة الصحة- سلطنة عُمان وزارة الصحة العامة وزارة الصحة | مملكة البحرين 🇧🇭 وزارة الصحة - الكويت

AI is no longer a pilot project in Gulf healthcare. In the UAE, one system alone is screening thousands of patients a da...
26/08/2026

AI is no longer a pilot project in Gulf healthcare. In the UAE, one system alone is screening thousands of patients a day.
M42’s AIRIS-TB, an AI-driven chest X-ray system, processes up to 2,000 scans daily for tuberculosis screening in the UAE, reducing radiologist workload by up to 80%. It’s one signal among several pointing to how quickly AI has moved from pilot to production across the region.
The data points shaping this shift:
Clinical deployment: M42’s AIRIS-TB processes up to 2,000 chest X-rays daily, cutting radiologist workload by up to 80%.
National strategy: Saudi Arabia’s National AI Strategy is actively extending AI tools into healthcare delivery.
Market growth: Dubai’s AI-in-healthcare market is projected to grow at a 34.6% compound annual rate, reaching roughly USD 138 million by 2030.
Broader digital health: the UAE’s overall digital health market is projected to reach approximately AED 4.7 billion (about USD 1.3 billion) by 2030.
Which use case — diagnostics, screening, or predictive analytics — do you see delivering the fastest population health return?

25/08/2026

🇦🇪 19 healthcare-AI prototypes. More than 100 original registrations. Now comes the difficult part.

Burjeel Holdings’ AiMed Solutions and Burjeel Training Academy have selected 19 finalists for the UAE’s AI Builders Summit 2026.

Their prototypes span clinical decision support, predictive analytics, patient experience, healthcare operations, population health and medical education.

But an important qualification:

⚠️ These are prototypes — not validated clinical products or approved medical devices.

For me, the real test begins after demo day.

Which solutions address a genuine clinical problem?

Which can be validated safely?

Which fit into actual clinical workflows?

And ultimately, which can demonstrate measurable improvements in outcomes, experience or efficiency?

🎥 That’s what I discuss in today’s Majlis Minute.

Burjeel Holdings دائرة الصحة - أبوظبي "DoH" وكالة أنباء الإمارات "وام"

📖 Source:
https://www.bignewsnetwork.com/news/279261886/ai-builders-summit-2026-to-spotlight-uae-emerging-healthcare-ai-innovators

21/08/2026

🇸🇦 Saudi Arabia is taking aim at a major healthcare bottleneck.

From 01/11/2026, health insurers in the Kingdom must offer an outpatient insurance product that does not require prior medical authorisation.

But there is an important distinction:

⚠️ This is not the removal of prior approvals from every existing insurance policy.

It is an additional product option that employers and policyholders must actively select.

The potential impact:

✅ Faster access to outpatient care
✅ Fewer administrative delays
✅ Less friction for patients and healthcare providers
✅ Greater choice for employers

However, insurers will also need stronger utilisation monitoring, fraud controls, claims analytics and post-payment auditing.

The biggest unanswered questions are how the product will be priced, what coverage limits will apply and whether employers will select it for their workforces.

🎥 I discuss what this could mean for healthcare access in today’s Majlis Minute.

هيئة التأمين | Insurance Authority

Official sources:

https://www.ia.gov.sa/en/media-center/news/123

https://www.spa.gov.sa/en/N2658442

HEOR. HTA. QALY. BIM. The acronyms are everywhere in Gulf market access conversations. Here’s what they actually mean. W...
21/08/2026

HEOR. HTA. QALY. BIM. The acronyms are everywhere in Gulf market access conversations. Here’s what they actually mean.
With DUPHAT 2026 (31st edition) and IFM 2026 (13th International Family Medicine Conference) both taking place 25–27 August at the Dubai World Trade Centre, this carousel breaks down the core terminology every team needs before engaging GCC payers and regulators.
1 - HEOR (Health Economics and Outcomes Research): the discipline linking clinical evidence to economic value.
2- HTA (Health Technology Assessment): how GCC payers decide whether an intervention is worth its cost relative to alternatives.
3 - CEA (Cost-Effectiveness Analysis): comparing the cost of an intervention against the health outcome it delivers.
4 - BIM (Budget Impact Model): what an intervention will cost the health system over the next 1–5 years.
5 - QALY (Quality-Adjusted Life Year): the standard unit used to measure health gain across interventions.
Swipe through, and drop a comment if you’d like a deeper explainer on any of these terms. Catch us at DUPHAT & IFM 2026, 25–27 August in Dubai.

Today the world marks World Humanitarian Day. In the Gulf, the humanitarian mission and the health-security mission incr...
19/08/2026

Today the world marks World Humanitarian Day. In the Gulf, the humanitarian mission and the health-security mission increasingly overlap.
Observed every 19 August since its establishment by the UN General Assembly in 2008, World Humanitarian Day honours humanitarian and aid workers, commemorating the 2003 bombing of the UN headquarters in Baghdad. For a region positioned at the crossroads of Africa, Asia and Europe, the observance carries direct relevance to how GCC states plan emergency medical response.
Why this matters strategically:
Cross-border coordination: regional health authorities increasingly partner with humanitarian agencies on emergency medical logistics.
Stockpiling and logistics: continued Gulf investment in medical supply-chain resilience supports both domestic and regional humanitarian response.
Workforce: frontline health workers — from field hospitals to disaster medicine specialists — remain the backbone of humanitarian response capacity.
Strategic framing: emergency preparedness functions as public health infrastructure, not a one-off crisis response.
How does your organization factor humanitarian health coordination into its emergency preparedness planning?

18/08/2026

EPISODE 3 | FROM VISION TO VALUE

A healthcare vision is not a document. It is a promise about what should change in a person’s life.

Across the GCC, six countries are following different healthcare roadmaps - from Saudi system redesign and the UAE’s federated model, to Oman’s long horizon, Qatar’s measurable outcomes, Bahrain’s financing reforms and Kuwait’s visible delivery.

This is not a ranking. The practical question is whether national ambition becomes better care.

In the episode, I use six tests:
Outcomes.
Patient journey.
Accountability.
Equity.
Evidence and data.
Sustainability and capability.

A vision becomes real only when the patient experiences the difference.

Watch the full episode through the link in my bio.

Which test matters most to you?

Official organisations referenced:
مجلس الصحة الخليجي وزارة الصحة السعودية وزارة الصحة ووقاية المجتمع وزارة الصحة- سلطنة عُمان وزارة الصحة العامة وزارة الصحة | مملكة البحرين 🇧🇭 وزارة الصحة - الكويت

Address

One Business Center, Media 1 Tower
Dubai

Website

Alerts

Be the first to know and let us send you an email when Al-Ghaf Dynamics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Al-Ghaf Dynamics:

Shortcuts

Share

Category